SCHEMBL1315430

SCHEMBL1315430

O=C(O)c1cc(C2CCNCC2)ccc1O

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACMSD Q8TDX5 2/20 0.73
QDPR P09417 1/20 0.65
PTGS2 P35354 2/20 0.47
MEN1 O00255 2/20 0.47
KDR P35968 2/20 0.47
KMT2A Q03164 2/20 0.47
KDM4E B2RXH2 1/20 0.47
ALDH1A1 P00352 1/20 0.47
TNF P01375 1/20 0.47
CYP3A4 P08684 1/20 0.47
HSPD1 P10809 1/20 0.47
THRB P10828 1/20 0.47
CYP2C9 P11712 1/20 0.47
HPGD P15428 1/20 0.47
ALOX15 P16050 1/20 0.47
CASP1 P29466 1/20 0.47
CYP2C19 P33261 1/20 0.47
BRCA1 P38398 1/20 0.47
RECQL P46063 1/20 0.47
CASP7 P55210 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27881571 0.88 ACMSD (0.86) ACMSDQDPRPTGS2MEN1KDR
SCHEMBL2533359 0.83 ACMSD (1.00) ACMSDPTGS2MEN1KDRKMT2A
SCHEMBL27965931 0.83 ACMSD (1.00) ACMSDPTGS2MEN1KDRKMT2A
SCHEMBL13406397 0.83 ACMSD (0.50) ACMSDQDPRSIGMAR1SLC18A3TBK1
SCHEMBL13646142 0.83 ACMSD (0.50) ACMSDQDPRSIGMAR1SLC18A3TBK1
SCHEMBL7148469 0.82 ACMSD (0.76) ACMSDQDPRPTGS2MEN1KDR
Hydrochloric Acid SCHEMBL28221719 0.81 ACMSD (0.49) ACMSDQDPRSIGMAR1SLC18A3TBK1
SCHEMBL7147427 0.81 ACMSD (0.73) ACMSDQDPRPTGS2MEN1KDR
SCHEMBL6535512 0.81 ACMSD (0.73) ACMSDQDPRPTGS2MEN1KDR
SCHEMBL31583726 0.79 QDPR (0.50) ACMSDQDPRSIGMAR1SLC18A3TBK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102333757-B N-acyl anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO LTD 2014-11-26 CN disclosed
US-8492582-B2 N-acyl anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2013-07-23 US disclosed
US-8492582-B2 N-acyl anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2013-07-23 US disclosed
US-20110275797-A1 N-ACYL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2011-11-10 US disclosed
US-20110275797-A1 N-ACYL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2011-11-10 US disclosed
EP-2385036-A1 N-ACYL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF Toyama Chemical Co., Ltd. (JP) 2011-11-09 EP disclosed
WO-2010087430-A1 N-ACYL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF 富山化学工業株式会社 (JP) 2010-08-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110275797-A1 N-ACYL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF COL14A1, COL2A1, COL1A1 ACMSD 74/4885QDPR 3137/4885PTGS2 2612/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.